Table 2.
Retained at 30 days (n = 90) | Not retained at 30 days (n = 25) | ||
---|---|---|---|
Characteristics | N (%) | N (%) | pa |
Sociodemographic | |||
Age (younger than median, 46 years) | 44 (48.9) | 11 (44.0) | .67 |
Male gender | 66 (73.3) | 19 (76.0) | .79 |
Race | .44 | ||
Hispanic | 59 (65.6) | 19 (76.0) | |
Non-Hispanic Black | 20 (22.2) | 5 (20.0) | |
Non-Hispanic other | 11 (12.2) | 1 (4.0) | |
Employed | 31 (34.4) | 6 (24.0) | .32 |
Have Medicaid | 67 (74.4) | 22 (88.0) | .15 b |
Drug use behaviors | |||
Substance use in past 30 days | |||
Heroin | 61 (67.8) | 20 (80.0) | .24 |
Street methadone | 31 (34.4) | 5 (20.0) | .17 b |
Methadone, prescribed in treatment | 26 (28.9) | 9 (36.0) | .49 |
Street prescription opioids | 9 (10.1) | 3 (12.5) | .72 |
Prescription opioids, prescribed in treatment | 13 (14.6) | 5 (20.0) | .54 |
Cocaine/Crack | 36 (40.0) | 11 (44.0) | .72 |
Sedative/Benzodiazepines | 10 (11.6) | 5 (20.8) | .31 |
Ever injected drugs | 51 (57.3) | 15 (62.5) | .64 |
Years using opioids ≥ median (≥22 years) | 45 (53.6) | 9 (39.1) | .22 |
Prior methadone treatment | 66 (73.0) | 19 (76.0) | .79 |
Prior buprenorphine use | 25 (27.8) | 6 (24.0) | .71 |
Treatment | |||
Home-based induction | 40 (44.4) | 11 (44.4) | .97 |
p value associated with chi-square test of difference in proportions for those retained at 30 days versus those not retained at 30 days for each characteristic.
p <.20, variable selected for inclusion in multivariable analyses.